| Nanotechnology in agri-food production: an overview BS Sekhon Nanotechnology, science and applications, 31-53, 2014 | 1115 | 2014 |
| Food nanotechnology–an overview BS Sekhon Nanotechnology, science and applications, 1-15, 2010 | 649 | 2010 |
| An overview of advances in the standardization of herbal drugs N Choudhary, BS Sekhon Journal of Pharmaceutical Education and Research 2 (2), 55, 2011 | 268 | 2011 |
| Pharmaceutical co-crystals-a review BS Sekhon Universidad de Granada, Facultad de Farmacia, 2009 | 218 | 2009 |
| Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases A Singh Grewal, S Bhardwaj, D Pandita, V Lather, B Singh Sekhon Mini reviews in medicinal chemistry 16 (2), 120-162, 2016 | 214 | 2016 |
| Prebiotics, probiotics and synbiotics: an overview. BS Sekhon, S Jairath Journal of Pharmaceutical Education & Research 1 (2), 2010 | 174 | 2010 |
| Reactive oxygen species and antioxidants in plants: an overview V Pandhair, BS Sekhon Journal of plant Biochemistry and Biotechnology 15, 71-78, 2006 | 154 | 2006 |
| Biosimilars: an overview BS Sekhon, V Saluja Biosimilars, 1-11, 2011 | 152 | 2011 |
| Matrix metalloproteinases–an overview BS Sekhon Research and Reports in Biology, 1-20, 2010 | 144 | 2010 |
| Chiral pesticides BS Sekhon Journal of Pesticide Science 34 (1), 1-12, 2009 | 143 | 2009 |
| Exploiting the power of stereochemistry in drugs: an overview of racemic and enantiopure drugs BS Sekhon J. Mod. Med. Chem 1 (10), 10-36, 2013 | 119 | 2013 |
| Inorganic nanomedicine—part 2 BS Sekhon, SR Kamboj Nanomedicine: Nanotechnology, Biology and Medicine 6 (5), 612-618, 2010 | 113 | 2010 |
| Enantioseparation of chiral drugs—an overview BS Sekhon Int J Pharm Technol Res 2, 1584-1594, 2010 | 107 | 2010 |
| Surfactants: pharmaceutical and medicinal aspects BS Sekhon Journal of Pharmaceutical Technology, Research and Management 1 (1), 43-68, 2013 | 97 | 2013 |
| Inorganic nanomedicine—part 1 BS Sekhon, SR Kamboj Nanomedicine: Nanotechnology, Biology and Medicine 6 (4), 516-522, 2010 | 85 | 2010 |
| Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus A Singh Grewal, B Singh Sekhon, V Lather Mini Reviews in Medicinal Chemistry 14 (7), 585-602, 2014 | 83 | 2014 |
| Drug-drug co-crystals BS Sekhon DARU Journal of Pharmaceutical Sciences 20 (1), 45, 2012 | 79 | 2012 |
| Supercritical fluid technology: an overview of pharmaceutical applications BS Sekhon International Journal of PharmTech Research 2 (1), 810-826, 2010 | 78 | 2010 |
| Gemini (dimeric) surfactants: The two-faced molecules BS Sekhon Resonance 9, 42-49, 2004 | 77 | 2004 |
| Biopharmaceuticals: an overview BS Sekhon Thai J. Pharm. Sci 34 (34), 1-19, 2010 | 69 | 2010 |
Vikrant SalujaAssociate Professor, Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, LudhianaVerified email at pcte.edu.in
